Advances in Immunotherapy for Tuberculosis Treatment

被引：44

作者：

Churchyard, Gavin J. ^{[1
,2
,3
]}

Kaplan, Gilla ^{[4
]}

Fallows, Dorothy ^{[4
]}

Wallis, Robert S. ^{[5
]}

Onyebujoh, Philip ^{[6
]}

Rook, Graham A. ^{[7
]}

机构：

[1] Aurum Inst Hlth Res, ZA-2041 Johannesburg, South Africa

[2] Univ KwaZulu Natal, Nelson R Mandela Sch Med, ZA-4041 Durban, South Africa

[3] Univ Cape Town, Fac Hlth Sci, ZA-7935 Cape Town, South Africa

[4] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA

[5] Pfizer Global Res & Dev, New London, CT 06320 USA

[6] WHO, Trop Dis Res, CH-1211 Geneva 27, Switzerland

[7] Royal Free & Univ Coll Med Sch, Ctr Infect Dis & Int Hlth, Windeyer Inst Med Sci, London W1P 7PP, England

来源：

CLINICS IN CHEST MEDICINE | 2009年 / 30卷 / 04期

关键词：

Tuberculosis; Immunotherapeutics; Antituberculous; Chemotherapy; Pulmonary infection; Immunopathology; TB treatment; NECROSIS-FACTOR-ALPHA; KILLED MYCOBACTERIUM-VACCAE; MULTIDRUG-RESISTANT TUBERCULOSIS; ADJUNCTIVE THALIDOMIDE THERAPY; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; IFN-GAMMA; T-CELLS; ANTITUBERCULOSIS TREATMENT; ANTIINFLAMMATORY ACTIVITY;

D O I：

10.1016/j.ccm.2009.08.009

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Immunotherapies have the potential to improve the outcome in all patients with tuberculosis (TB) including those with multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB. Immunotherapy for TB may shorten duration of treatment and reduce pathology in individuals cured by chemotherapy, potentially preventing recurrence. Currently none of the available candidate agents have proof of efficacy for use in MDR-TB or XDR-TB. Further development and evaluation of existing immunotherapeutic agents is required to identify an effective agent that can be used adjunctively with chemotherapy to improve treatment outcomes for drug-susceptible TB, MDR-TB, and XDR-TB. With a range of potential immunotherapeutics, some of which have been produced to good manufacturing practice (GMP) standards and are registered for other indications in humans, the immunotherapy option should no longer be ignored.

引用

页码：769 / +

页数：15

共 101 条

[11] Immunomodulation by thalidomide and thalidomide analogues [J].

Corral, LG ;

Kaplan, G .

ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 :107-113

[12] Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity [J].

Corral, LG ;

Muller, GW ;

Moreira, AL ;

Chen, YX ;

Wu, MD ;

Stirling, D ;

Kaplan, G .

MOLECULAR MEDICINE, 1996, 2 (04) :506-515

[13]

de Vallière S, 2004, INT J TUBERC LUNG D, V8, P767

[14] Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism [J].

Deretic, V ;

Singh, S ;

Master, S ;

Harris, J ;

Roberts, E ;

Kyei, G ;

Davis, A ;

de Haro, S ;

Naylor, J ;

Lee, HH ;

Vergne, I .

CELLULAR MICROBIOLOGY, 2006, 8 (05) :719-727

[15] The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis [J].

Diacon, Andreas H. ;

Pym, Alexander ;

Grobusch, Martin ;

Patientia, Ramonde ;

Rustomjee, Roxana ;

Page-Shipp, Liesl ;

Pistorius, Christoffel ;

Krause, Rene ;

Bogoshi, Mampedi ;

Churchyard, Gavin ;

Venter, Amour ;

Allen, Jenny ;

Palomino, Juan Carlos ;

De Marez, Tine ;

van Heeswijk, Rolf P. G. ;

Lounis, Nacer ;

Meyvisch, Paul ;

Verbeeck, Johan ;

Parys, Wim ;

de Beule, Karel ;

Andries, Koen ;

Mc Neeley, David F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) :2397-2405

[16] Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis [J].

Dlugovitzky, Diana ;

Fiorenza, Gladys ;

Farroni, Miguel ;

Bogue, Christine ;

Stanford, Cynthia ;

Stanford, John .

RESPIRATORY MEDICINE, 2006, 100 (06) :1079-1087

[17] Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis [J].

Elias-Lopez, A. L. ;

Marquina, B. ;

Gutierrez-Ortega, A. ;

Aguilar, D. ;

Gomez-Lim, M. ;

Hernandez-Pando, R. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 (01) :123-133

[18]

[范妙仪 FAN Miaoyi], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P449

[19] Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis [J].

Fenton, MJ ;

Vermeulen, MW ;

Kim, S ;

Burdick, M ;

Strieter, RM ;

Kornfeld, H .

INFECTION AND IMMUNITY, 1997, 65 (12) :5149-5156

[20] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].

FLYNN, JL ;

GOLDSTEIN, MM ;

CHAN, J ;

TRIEBOLD, KJ ;

PFEFFER, K ;

LOWENSTEIN, CJ ;

SCHREIBER, R ;

MAK, TW ;

BLOOM, BR .

IMMUNITY, 1995, 2 (06) :561-572

← 1 2 3 4 5 6 7 8 9 10 →